Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Shares Shorted: Short Interest Down 69.1% in September

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the target of a large drop in short interest in September. As of September 15th, there was short interest totaling 84,256 shares, a drop of 69.1% from the August 31st total of 272,812 shares. Based on an average daily trading volume, of 172,085 shares, the short-interest ratio is currently 0.5 days. Currently, 1.3% of the shares of the stock are short sold.

Creative Medical Technology Stock Performance

NASDAQ CELZ traded up $0.06 on Friday, hitting $1.03. 318,235 shares of the stock were exchanged, compared to its average volume of 1,251,462. Creative Medical Technology has a 52-week low of $0.62 and a 52-week high of $6.25. The firm has a market capitalization of $6.79 million, a P/E ratio of -0.50 and a beta of 2.04. The stock has a fifty day moving average price of $1.01 and a two-hundred day moving average price of $1.62.

Creative Medical Technology (NASDAQ:CELZ) last announced its earnings results on Friday, August 7th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.02). Sell-side analysts expect that Creative Medical Technology will post -1.18 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CELZ shares. Wall Street Zen upgraded shares of Creative Medical Technology from a “sell” rating to a “hold” rating in a research report on Saturday, September 12th. Weiss Ratings lowered Creative Medical Technology from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday. Finally, Roth Capital reissued a “buy” rating on shares of Creative Medical Technology in a research note on Thursday, August 20th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold”.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc is a biotechnology company focused on developing regenerative medicine and cell-based therapies. The company’s research programs are aimed at conditions involving inflammation, autoimmune dysfunction, tissue damage and sexual health.

Its pipeline has included ImmCelz, an immunomodulatory cell-therapy platform, as well as CaverStem for erectile dysfunction, FemCelz for female sexual health, KneeCelz for knee-related conditions and StemSpine for spinal disorders.